Search research articles
Contact Us
Filters
Showing results (571-580 of 683) with videos related to
Page
of 69
Sort By:
Cell
|
September 17, 2021
Genome-wide functional screen of 3'UTR variants uncovers causal variants for human disease and evolution
Dustin Griesemer, James R Xue, Steven K Reilly, et al.
Plos Genetics
|
November 17, 2018
Functional regulatory mechanism of smooth muscle cell-restricted LMOD1 coronary artery disease locus
Vivek Nanda, Ting Wang, Milos Pjanic, et al.
Genome Research
|
March 20, 2025
Integration of transcriptomics and long-read genomics prioritizes structural variants in rare disease
Tanner D Jensen, Bohan Ni, Chloe M Reuter, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 8, 2024
Integration of transcriptomics and long-read genomics prioritizes structural variants in rare disease
Tanner D Jensen, Bohan Ni, Chloe M Reuter, et al.
Nature
|
October 13, 2017
The impact of rare variation on gene expression across tissues
Xin Li, Yungil Kim, Emily K Tsang, et al.
Plos Genetics
|
April 26, 2012
Patterns of cis regulatory variation in diverse human populations
Barbara E Stranger, Stephen B Montgomery, Antigone S Dimas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2014
Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors
Eddy J Chen, Adam G Sowalsky, Shuai Gao, et al.
Prostate Cancer and Prostatic Diseases
|
January 21, 2015
Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel
H H Cheng, R Gulati, A Azad, et al.
JCO Precision Oncology
|
April 25, 2024
Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to <sup>177</sup>Lu-PSMA-617: A Retrospective Multicenter Cohort Study
Ruben Raychaudhuri, George Mo, Abuzar Moradi Tuchayi, et al.
Cancer Immunology, Immunotherapy : CII
|
August 23, 2022
Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma
Guru P Sonpavde, Benjamin Louis Maughan, Bradley Alexander McGregor, et al.
Page
of 69
Search research articles
Search
Showing results (571-580 of 683) with videos related to
Sort By:
Page
of 69
Cell
|
September 17, 2021
Genome-wide functional screen of 3'UTR variants uncovers causal variants for human disease and evolution
Dustin Griesemer, James R Xue, Steven K Reilly, et al.
Plos Genetics
|
November 17, 2018
Functional regulatory mechanism of smooth muscle cell-restricted LMOD1 coronary artery disease locus
Vivek Nanda, Ting Wang, Milos Pjanic, et al.
Genome Research
|
March 20, 2025
Integration of transcriptomics and long-read genomics prioritizes structural variants in rare disease
Tanner D Jensen, Bohan Ni, Chloe M Reuter, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 8, 2024
Integration of transcriptomics and long-read genomics prioritizes structural variants in rare disease
Tanner D Jensen, Bohan Ni, Chloe M Reuter, et al.
Nature
|
October 13, 2017
The impact of rare variation on gene expression across tissues
Xin Li, Yungil Kim, Emily K Tsang, et al.
Plos Genetics
|
April 26, 2012
Patterns of cis regulatory variation in diverse human populations
Barbara E Stranger, Stephen B Montgomery, Antigone S Dimas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2014
Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors
Eddy J Chen, Adam G Sowalsky, Shuai Gao, et al.
Prostate Cancer and Prostatic Diseases
|
January 21, 2015
Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel
H H Cheng, R Gulati, A Azad, et al.
JCO Precision Oncology
|
April 25, 2024
Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to <sup>177</sup>Lu-PSMA-617: A Retrospective Multicenter Cohort Study
Ruben Raychaudhuri, George Mo, Abuzar Moradi Tuchayi, et al.
Cancer Immunology, Immunotherapy : CII
|
August 23, 2022
Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma
Guru P Sonpavde, Benjamin Louis Maughan, Bradley Alexander McGregor, et al.
Page
of 69